Literature DB >> 4895897

The side-effects of carbamazepine.

J J Gayford, T H Redpath.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4895897      PMCID: PMC1811081     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  12 in total

1.  THE TREATMENT OF TRIGEMINAL NEURALGIA: PRELIMINARY EXPERIENCE WITH 'TEGRETOL'.

Authors:  J D SPILLANE
Journal:  Practitioner       Date:  1964-01

2.  Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G-32883).

Authors:  S BLOM
Journal:  Lancet       Date:  1962-04-21       Impact factor: 79.321

3.  Controlled sequential trials of carbamazepine in trigeminal neuralgia.

Authors:  B W Rockliff; E H Davis
Journal:  Arch Neurol       Date:  1966-08

4.  Aplastic anaemia following the administration of tegretol.

Authors:  G W Donaldson; J G Graham
Journal:  Br J Clin Pract       Date:  1965-12

5.  The side effects of carbamazepine therapy.

Authors:  T H Redpath; J J Gayford
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1968-09

6.  Aplastic anaemia after carbamazepine.

Authors:  N H Dyer; D T Hughes; G C Jenkins
Journal:  Br Med J       Date:  1966-01-08

7.  A new agent in the treatment of tic douloureux: a preliminary report.

Authors:  D J Dalessio; K H Abbott
Journal:  Headache       Date:  1966-01       Impact factor: 5.887

8.  Treatment of tic douloureux with tegretol.

Authors:  T J Walsh; J L Smith
Journal:  Am J Ophthalmol       Date:  1966-03       Impact factor: 5.258

9.  Carbamazepine-induced jaundice.

Authors:  I D Ramsay
Journal:  Br Med J       Date:  1967-10-28

10.  "Collagen disease" due to carbamazepine (Tegretol).

Authors:  J R Simpson
Journal:  Br Med J       Date:  1966-12-10
View more
  7 in total

Review 1.  Carbamazepine in bipolar disorder with pain: reviewing treatment guidelines.

Authors:  Tahir Rahman; Austin Campbell; Christopher R O'Connell; Kishan Nallapula
Journal:  Prim Care Companion CNS Disord       Date:  2014-10-09

2.  Blast transformation in vivo and in vitro in carbamazepin hypersensitivity.

Authors:  M Virolainen
Journal:  Clin Exp Immunol       Date:  1971-09       Impact factor: 4.330

3.  Serum anticonvulsant concentrations and the risk of drug induced skin eruptions.

Authors:  D Chadwick; M D Shaw; P Foy; M D Rawlins; D M Turnbull
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-06       Impact factor: 10.154

4.  Glandular fever-like syndrome, pulmonary eosinophilia and asthma associated with carbamazepine.

Authors:  I J Lewis; L Rosenbloom
Journal:  Postgrad Med J       Date:  1982-02       Impact factor: 2.401

5.  The Mechanistic Differences in HLA-Associated Carbamazepine Hypersensitivity.

Authors:  Gwendolin S Simper; Lareen S Gräser; Alexander A Celik; Joachim Kuhn; Heike Kunze-Schumacher; Gia-Gia T Hò; Rainer Blasczyk; Andreas Pich; Christina Bade-Doeding
Journal:  Pharmaceutics       Date:  2019-10-15       Impact factor: 6.321

6.  Expression of human solute carrier family transporters in skin: possible contributor to drug-induced skin disorders.

Authors:  Ryoichi Fujiwara; Saya Takenaka; Mitsuhiro Hashimoto; Tomoya Narawa; Tomoo Itoh
Journal:  Sci Rep       Date:  2014-06-11       Impact factor: 4.379

7.  Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B∗15:02.

Authors:  Gwendolin S Simper; Gia-Gia T Hò; Alexander A Celik; Trevor Huyton; Joachim Kuhn; Heike Kunze-Schumacher; Rainer Blasczyk; Christina Bade-Döding
Journal:  J Immunol Res       Date:  2018-09-13       Impact factor: 4.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.